Literature DB >> 9418184

Altered expression and function of P-glycoprotein (170 kDa), encoded by the MDR 1 gene, in T cell subsets from aging humans.

S Aggarwal1, T Tsuruo, S Gupta.   

Abstract

Aging is associated with progressive T cell-mediated immune deficiency, increased frequency of infections, and autoimmune phenomena. P-glycoprotein (P-gP), a 170-kDa glycoprotein, is a member of a superfamily of ATP-binding cassette transport proteins that has been shown to express on cells of the immune system and suggested to play a role in secretion of certain cytokines and cytotoxic molecules. Because aging is associated with altered secretion of cytokines, in this investigation we examined the expression and function of P-gP in CD4+ and CD8+ T cells and their "memory" and "naïve" subpopulations in peripheral blood from healthy aging and young subjects. P-glycoprotein expression was analyzed at the protein levels by dual- or triple-color flow cytometric analysis, using monoclonal antibodies against P-gP (MRK16), and at the mRNA level by quantitative reverse-transcriptase polymerase chain reaction. The efflux function of P-gP was measured by intracellular accumulation of rhodamine-123 (Rh123; a substrate for P-gP) in the presence or absence of cyclosporin A (which binds to P-gP and inhibits its efflux function). The data show increased expression of P-gP at both the protein and the mRNA levels in aging lymphocytes. Increased P-gP expression, at the protein level, was also observed in naïve cell subpopulations from aging CD4+ and CD8+ T cell subsets compared to those from young controls. An increase in P-gP function, as measured by the ability of T cell subsets to efflux Rh123, was observed in aging CD4+ and CD8+ T cell subsets and their naïve and memory subpopulations. These data suggest that altered P-gP expression and function in aging may play a role in changes in immune response, including cytokine secretion, associated with human aging.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9418184     DOI: 10.1023/a:1027363525408

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  40 in total

1.  Functional role for the 170- to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies.

Authors:  H Hamada; T Tsuruo
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

2.  Identification of the multidrug resistance-related P-glycoprotein as a cyclosporine binding protein.

Authors:  B M Foxwell; A Mackie; V Ling; B Ryffel
Journal:  Mol Pharmacol       Date:  1989-10       Impact factor: 4.436

3.  Monoclonal antibodies against P-glycoprotein, an MDR1 gene product, inhibit interleukin-2 release from PHA-activated lymphocytes.

Authors:  G Raghu; S W Park; I B Roninson; E B Mechetner
Journal:  Exp Hematol       Date:  1996-08       Impact factor: 3.084

4.  Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells.

Authors:  P M Chaudhary; I B Roninson
Journal:  Cell       Date:  1991-07-12       Impact factor: 41.582

5.  Mdr1/P-glycoprotein expression in natural killer (NK) cells enriched from peripheral or umbilical cord blood.

Authors:  A Wilisch; A Noller; R Handgretinger; S Weger; V Nüssler; D Niethammer; H Probst; V Gekeler
Journal:  Cancer Lett       Date:  1993-04-30       Impact factor: 8.679

Review 6.  The role of the MDR1 (P-glycoprotein) gene in multidrug resistance in vitro and in vivo.

Authors:  I B Roninson
Journal:  Biochem Pharmacol       Date:  1992-01-09       Impact factor: 5.858

7.  Age-related changes in human lymphocyte subsets: progressive reduction of the CD4 CD45R (suppressor inducer) population.

Authors:  P De Paoli; S Battistin; G F Santini
Journal:  Clin Immunol Immunopathol       Date:  1988-09

8.  P-glycoprotein expression and function in circulating blood cells from normal volunteers.

Authors:  W T Klimecki; B W Futscher; T M Grogan; W S Dalton
Journal:  Blood       Date:  1994-05-01       Impact factor: 22.113

9.  Human immunodeficiency virus I-induced expression of P-glycoprotein.

Authors:  S Gollapudi; S Gupta
Journal:  Biochem Biophys Res Commun       Date:  1990-09-28       Impact factor: 3.575

10.  Differences in the expression profiles of CD45RB, Pgp-1, and 3G11 membrane antigens and in the patterns of lymphokine secretion by splenic CD4+ T cells from young and aged mice.

Authors:  D N Ernst; M V Hobbs; B E Torbett; A L Glasebrook; M A Rehse; K Bottomly; K Hayakawa; R R Hardy; W O Weigle
Journal:  J Immunol       Date:  1990-09-01       Impact factor: 5.422

View more
  10 in total

Review 1.  The impact of efflux transporters in the brain on the development of drugs for CNS disorders.

Authors:  Eve M Taylor
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

2.  A subset of virus-specific CD161+ T cells selectively express the multidrug transporter MDR1 and are resistant to chemotherapy in AML.

Authors:  Abdullah Alsuliman; Muharrem Muftuoglu; Ahmad Khoder; Yong-Oon Ahn; Rafet Basar; Michael R Verneris; Pawel Muranski; A John Barrett; Enli Liu; Li Li; Kate Stringaris; Darius Armstrong-James; Hila Shaim; Kayo Kondo; Nobuhiko Imahashi; Borje Andersson; David Marin; Richard E Champlin; Elizabeth J Shpall; Katayoun Rezvani
Journal:  Blood       Date:  2016-11-07       Impact factor: 22.113

3.  A human lymphocyte based ex vivo assay to study the effect of drugs on P-glycoprotein (P-gp) function.

Authors:  D A Parasrampuria; M V Lantz; L Z Benet
Journal:  Pharm Res       Date:  2001-01       Impact factor: 4.200

Review 4.  Pharmacokinetic considerations relating to tacrolimus dosing in the elderly.

Authors:  Christine E Staatz; Susan E Tett
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

5.  Expression of the Stem Cell Marker ABCB5 in Normal and Tumor Tissues.

Authors:  Mohamed E M Saeed; Joelle C Boulos; Kevin Machel; Nasim Andabili; Thamail Marouni; Wilfried Roth; Thomas Efferth
Journal:  In Vivo       Date:  2022 Jul-Aug       Impact factor: 2.406

6.  Plasma LDL cholesterol has no impact on P-glycoprotein (MDR1/ABCB1) activity in human peripheral blood mononuclear cells.

Authors:  Caroline Henrike Storch; Hans-Dieter Klimm; Tilman Heinrich; Walter Emil Haefeli; Johanna Weiss
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-07-26       Impact factor: 3.000

Review 7.  Expression of adenosine triphosphate-binding cassette (ABC) drug transporters in peripheral blood cells: relevance for physiology and pharmacotherapy.

Authors:  Kathleen Köck; Markus Grube; Gabriele Jedlitschky; Lena Oevermann; Werner Siegmund; Christoph A Ritter; Heyo K Kroemer
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

8.  ABCB1 (P-glycoprotein) but not ABCC1 (MRP1) is downregulated in peripheral blood mononuclear cells of spontaneously hypertensive rats.

Authors:  Raphael C Valente; Luiz S Capella; Clarissa R Nascimento; Filipe Braga; Juliana Echevarria-Lima; Aníbal G Lopes; Márcia A M Capella
Journal:  Pflugers Arch       Date:  2007-12-04       Impact factor: 3.657

9.  Renal tubular P-glycoprotein expression is reduced in plasma cell disorders.

Authors:  Cihan Heybeli; Mehmet Asi Oktan; Hayri Ustun Arda; Serkan Yildiz; Mehtat Unlu; Caner Cavdar; Aykut Sifil; Ali Celik; Sulen Sarioglu; Taner Camsari
Journal:  Kidney Res Clin Pract       Date:  2019-06-30

10.  Aging of the CD4 T Cell Compartment.

Authors:  Julie S Lefebvre; Laura Haynes
Journal:  Open Longev Sci       Date:  2012-01-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.